Stock & Company Details
Cue Biopharma Inc $CUE
Price:
N/A
N/A
7.3M
$154M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.89
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CUE technical indicators
Latest Cue Biopharma Inc (CUE) indicator readings as of 2026-10-29.
CUE's 14-day RSI is 48.2, in neutral territory. At $21.45 it is trading 21.1% above its 200-day moving average of $17.71, and below its 50-day average of $25.60. Price sits in the middle of its Bollinger Bands ($14.39 to $26.88). ADX reads 16.3, indicating a range-bound market rather than a trend.
Overview
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.
Finance Bot
Ask your questions
Start by typing a question below.
